<?xml version="1.0" encoding="utf-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd"><url><loc>https://www.auntminnie.com/clinical-news/ct/article/15831063/ct-radiation-doses-have-fallen-sharply-over-past-decade</loc><news:news><news:publication><news:name>AuntMinnie</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-28T19:18:29.000Z</news:publication_date><news:title>CT radiation doses have fallen sharply over past decade</news:title></news:news><image:image><image:loc>https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/ct-doses-2025.4VYwupxq8e.jpg?auto=format%252Ccompress&amp;q=70</image:loc><image:caption>Bar graphs show comparison of volume CT dose index (CTDIvol) (A) achievable doses (50th percentile) and (B) diagnostic reference levels (75th percentile) between 2014 (see reference 4 by Kanal et al) and 2025 (present study) for 10 common CT examination types performed without contrast (w/o) and with contrast (w/). Across all 10 adult CT examination categories, CTDIvol achievable doses and diagnostic reference levels generally decreased from 2014 to 2025, with the largest reductions for torso examinations (chest; abdomen-pelvis; and combined chest, abdomen, and pelvis), intermediate reductions for neck and cervical spine, and minimal change for head examinations.</image:caption></image:image></url><url><loc>https://www.auntminnie.com/clinical-news/womens-imaging/breast/article/15831053/cem-finds-breast-cancer-at-baseline-incidence-screening</loc><news:news><news:publication><news:name>AuntMinnie</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-28T19:16:10.000Z</news:publication_date><news:title>CEM finds breast cancer at baseline, incidence screening</news:title></news:news><image:image><image:loc>https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-28-radiology-cem.cjeTavBVbK.jpg?auto=format%252Ccompress&amp;q=70</image:loc><image:caption>Images in a 70-year-old asymptomatic woman with a prior excisional biopsy in the left breast yielding lobular carcinoma in situ 3 years earlier. Screening contrast-enhanced mammography (CEM) was performed, which was considered a prevalence screen as the woman had no prior breast MRI in the past 3 years and no prior CEM. &amp;lt;strong&amp;gt;(A)&amp;lt;/strong&amp;gt; Low-energy (26–30 kVp) mediolateral oblique (MLO) and &amp;lt;strong&amp;gt;(B)&amp;lt;/strong&amp;gt; craniocaudal (CC) views show surgical clips but no abnormality. &amp;lt;strong&amp;gt;(C)&amp;lt;/strong&amp;gt; Recombined MLO and &amp;lt;strong&amp;gt;(D)&amp;lt;/strong&amp;gt; CC images show an enhancing mass in the medial left breast (arrows). Biopsy revealed invasive lobular carcinoma. Size was 0.2 cm; tumor grade II/III; negative lymph nodes; and estrogen receptor–positive, progesterone receptor–positive, and human epidermal growth factor receptor 2–negative.</image:caption></image:image></url><url><loc>https://www.auntminnie.com/editors-note/article/15830872/week-in-review-minnies-nominations-are-open-ct-shows-pager-blast-damage-pluvicto-for-earlierstage-prostate-cancer</loc><news:news><news:publication><news:name>AuntMinnie</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-24T19:51:30.000Z</news:publication_date><news:title>Week in Review: Minnies nominations are open | CT shows pager blast damage | Pluvicto for earlier-stage prostate cancer</news:title></news:news></url><url><loc>https://www.auntminnie.com/clinical-news/molecular-imaging/article/15830851/spectct-viable-over-petct-for-highrisk-prostate-staging</loc><news:news><news:publication><news:name>AuntMinnie</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-24T18:35:52.000Z</news:publication_date><news:title>SPECT/CT viable over PET/CT for high-risk prostate cancer staging</news:title></news:news><image:image><image:loc>https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/spect-ct-vs-pet-ct.dxzBmRt2JJ.jpg?auto=format%252Ccompress&amp;q=70</image:loc><image:caption>Maximum intensity projection of Ga-68 PSMA-11 PET/CE-CT (A), Tc-99m MIP-1404 CZT SPECT/CT (B) and Tc-99m HDP CZT SPECT/CT (C) imaging. Ga-68 PSMA-11 PET/CE-CT and Tc-99m MIP-1404 CZT SPECT/CT showing tracer uptake in lymph nodes below the iliac bifurcation and above, paraaortic and left supraclavicular, bone uptake in the right proximal femur and right scapula (arrows). Tc-99m HDP CZT SPECT/CT did not show any uptake suspicious for metastatic disease. No sclerotic lesions suspicious of metastases were detected by the CT component in any of the studies. Fusion axial imaging of Ga-68 PSMA-11 PET/CE-CT (D) and Tc-99m MIP-1404 CZT SPECT/CT (E) showing uptake in lymph nodes in the left pelvic area below the iliac bifurcation (arrows). Fusion axial imaging of Ga-68 PSMA-11 PET/CE-CT (F) and Tc-99m MIP-1404 CZT SPECT/CT (G) showing uptake in the right proximal femur, not detected by Tc-99m HDP CZT SPECT/CT (H), (arrows).</image:caption></image:image></url><url><loc>https://www.auntminnie.com/clinical-news/ct/article/15830794/ct-scanner-placement-near-ed-cuts-stroke-imaging-times</loc><news:news><news:publication><news:name>AuntMinnie</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-23T21:57:09.000Z</news:publication_date><news:title>CT scanner placement near ED cuts stroke imaging times</news:title></news:news><image:image><image:loc>https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/emergency2.3ku4GIHJXX.jpg?auto=format%252Ccompress&amp;q=70</image:loc></image:image></url><url><loc>https://www.auntminnie.com/clinical-news/digital-x-ray/article/15830680/bone-health-declines-over-time-in-adolescents-with-diabetes</loc><news:news><news:publication><news:name>AuntMinnie</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-22T21:31:20.000Z</news:publication_date><news:title>Bone health declines over time in adolescents with diabetes</news:title></news:news><image:image><image:loc>https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/dexa.vId81UK3k9.jpg?auto=format%252Ccompress&amp;q=70</image:loc></image:image></url><url><loc>https://www.auntminnie.com/clinical-news/digital-x-ray/article/15830652/are-chest-xrays-useful-in-children-with-recurrent-wheezing</loc><news:news><news:publication><news:name>AuntMinnie</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-22T19:18:57.000Z</news:publication_date><news:title>Are chest x-rays useful in children with recurrent wheezing?</news:title></news:news><image:image><image:loc>https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/preschoolers.JmDj4292Eq.jpg?auto=format%252Ccompress&amp;q=70</image:loc></image:image></url><url><loc>https://www.auntminnie.com/editors-note/article/15830559/auntminniecom-molecular-imaging-insider</loc><news:news><news:publication><news:name>AuntMinnie</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-21T21:00:35.000Z</news:publication_date><news:title>AuntMinnie.com Molecular Imaging Insider</news:title></news:news></url></urlset>